Travel medicine working group  by Macchi, A. et al.
e th In
r
n
f
(
f
(
(
1
e
o
d
s
l
t
t
(
e
u
f
0
e
w
a
o
s
t
v
p
c
i
d
3
I
S
F
1
2
3
4
i
t
o
c
s
a
e
t
n
a
h
(
1
f
t
c
(
4
t
e
i
S
t
m
t
p
(
c
e
c
d
o
w
t
d
3
T
A
V
A
1
2
3
4
A
e
o
A
a142 14
eports of travellers with clinical and epidemiological diag-
osis of NWCL, assisted from 1994 through 2008.
Results: 39 cases of NWCL were recorded (29 males, 10
emales, with age ranged from 17 to 72 years). Twenty-nine
74%) patients were residents of Argentina, 10 (26%) were
oreigners in transit. The reason for travel was tourism in 21
54%), work 14 (36%) and friends and relatives visit (VFR) 4
10%).
26 patients (67%) acquired the disease outside Argentina;
3 (33%) in Argentina, who were domestic travelers to
ndemic areas.
At query time 16 (41%) patients had lesions 30 to 60 days
f development, 19 (49%) 75 to 120 days.
Estimated average time of exposure in risk area was 20
ays.
Thirty patients (77%) had multiple lesions and 9 (23%) had
ingle lesion.
84.61% of the lesions were ulcers; 67% of the lesions were
ocalized in the extremities, 23% of the face and 10% in
runk.
The diagnosis was made by direct microscopic examina-
ion in 29 (74%), and 10 (26%) by biopsy, 7 were cultured
5 were positive). No species identiﬁcation was made in
ither case. 36 patients received as ﬁrst treatment sched-
le meglumine antimoniate intramuscular (20mg/kg/day
or 21 days), 2 patients amphotericin B deoxycholate
.5mg/kg/day up to 1,5 grams total and 1 patient who trav-
lled around Panama received ﬂuconazole 200mg/day for 6
eeks. 4 patients treated with meglumine antimoniate had
dverse effects.
85% of patients cured with ﬁrst therapeutic regimen.
3 patients treated with antimonials reported relapses,
ne patient had therapeutic failure. All healed without sub-
equent relapse.
Conclusion: Cutaneous leishmaniasis is a risk for travelers
o tropical areas of America and is necessary to include pre-
ention guidelines in pre travel advisory. It is important that
hysician be trained in the recognition of this condition and
onsider the possibility of mucosal involvement in patients
nfected with L braziliensis.
oi:10.1016/j.ijid.2010.02.1797
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Background: Malaria is the most important parasitic
nfection that produces human disease. It is caused by pro-
ozoa of the genus Plasmodium and transmitted by the bite
f the female Anopheles mosquito. It’s endemic in over 90
ountries and is the most common speciﬁc etiologic diagno-
is in febrile travelers.
Methods: A retrospective, cross-sectional and descriptive
nalysis was performed based on medical reports of trav-
o
m
c
v
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llers with diagnosis of imported malaria, assisted from 1981
hrough 2008.
Results: Of 1010 returned travelers (domestic and inter-
ational) seen at our clinic, 337 (36.36%) patients cited fever
s a chief reason for seeking care and 143 (42.43%) of them
ad malaria.
There were 135 (94.40%) cases of imported malaria, 100
74.07%) males and 35 (25.92%) females, from 3 to 73 years.
27 (94.07%) travelers were residents.
The species involved was P. vivax in 61 cases (46.18%), P.
alciparum in 59 (43.70%); P.ovale in 1 (0.74%), mixed infec-
ions of P. falciparum and vivax malaria in 3 (2.22%) and 11
ases (8.14%) without identiﬁcation.
74 (54.81%) travelers acquired malaria in Africa, 48
35.55%) in South America, and 7 (5.18%) in Central America.
The reasons for travel were: 56 (41.48%) work/business;
7 (34.81%) tourism; 18 (13.33%) visiting friends and rela-
ives; 13 (9.62%) missionary/volunteer; and 1 (0.74%) per
ducation. In travelers to Africa the species most frequently
nvolved was P. falciparum (52/74, 70.27%) and P. vivax in
outh America (38/48, 79.16%).
Only 40 (2.96%) travelers received medical advice before
he trip, of them 32 (80%) received chemoprophylaxis for
alaria, 3 (9.37%) of which were inappropriate according
o the area visited. None of the chemoprophylaxis included
rimaquine. All patients improved with treatment. 5 / 59
8.47%) travelers had P. falciparum severe malaria.
Conclusion: In febrile returned traveler, we must always
onsider the diagnosis of malaria regardless of the time
lapsed since leaving the malaria area. Plasmodium fal-
iparum malaria is a medical emergency. The treatment
epends on the knowledge of the geographical distribution
f parasite resistance against antimalarial drugs, especially
hen no parasite species identiﬁcation is possible.
It should be emphasized prevention with personal pro-
ection measures and adequate chemoprophylaxis.
oi:10.1016/j.ijid.2010.02.1798
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Background: Travel Medicine Working Group (TMWG),
stablished in 1992, is the ﬁrst program for prevention
f travel medicine related infectious diseases in Buenos
ires. TMWG aims to improve travelers health and to raise
wareness of its importance to the argentinean public. The
bjective of this presentation is to describe the scope of a
ultidisciplinary TMWG.
Methods: TMWG comprises infectious diseases spe-
ialists, high-tech, up-to-date laboratory facilities and
accination centers. We designed a program aimed to assist
ravellers before departure, en route, after return and to
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optimize vaccination in adult population. Activities focus on
four basic areas:
Community-oriented education: travel-oriented
brochures and handouts, travel medicine newsletters
and travel warning.
Health care professional education: Seminars and sym-
posia, medical rounds, periodic work meetings and annual
courses.
Research: Characterization of medical consults.
Medical assistance: pre-travel consult, speciﬁc medi-
cal record, tailored counseling, telephone and electronic
real-time support and referral to local reference medical
centers. Post travel medical evaluation of asymptomatic
long-term travellers, prompt diagnosis and treatment of
symptomatic travellers and epidemiological surveillance
activities.
Results: Between 1992 and 2008 the TMWG has counseled
54,100 travelers. The average annual consult increase was
25% in last four years. In 1998 only 11.8% of high-risk travel-
ers consulted with enough anticipation; in 2008, 24%. 0.4% of
a sample of travelers came to our center referred by travel
agencies and 0.5% by embassies. Routine and special vac-
cine shots increased progressively each year. In a group of
10-50 years old travelers, 8.3% were susceptible to chicken-
pox, 11.4% to mumps, 10.2% to rubella and 8.9% to measles.
Hepatitis A seroprevalence was 40%.
Conclusion: Our experience shows this new medical spe-
cialty is increasingly demanded. We must deepen our work
in an interdisciplinary manner to obtain traveler referrals
from embassies and travel agencies, because of individual
and community travel associated health risks.
The development of TMWG has created awareness of
the need for pre travel advice in the medical and general
community and provides opportunities to update routine
vaccinations in adults.
doi:10.1016/j.ijid.2010.02.1799
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Proﬁle of imported malaria in travelers from the north of
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mento e Castro2
1 Hospital Joaquim Urbano, Porto, Portugal
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Background: Malaria was irradicated from Portugal since
the 50s, but every year, hundreds of Portuguese travelers
arriving from Malaria Endemic Countries are diagnosed plas-
modium positive.
The objective of this study is to investigate the clini-
cal and epidemiological imported malaria between January
2004 and October 2009 in the Travel Medicine Departament
of Hospital Joaquim Urbano in Porto - Portugal.
Methods: Review of the records and datas of 160 malaria
diagnosed positive cases, conﬁrmed by microscopy, in
the last 6 years.Variables analyzed: age, gender, country
visited, pre-travel consultation, chemoprophylaxis, plas-
modium species, reason of travel and symptoms.
Results: The average age of the 160 patients was 42,18
years old. From this group 108 patients (67,5%) were male.
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The main visited countries were Angola with 92 cases
57,5%), followed by Mozambique with 23 (14,4%), São Tomé
ith 7 (4,8%), and the rest distributed over ﬁfteen other
ountries.The most common agent of plasmodium identi-
ed by laboratorial exam was P.falciparum with 31 cases
19,38%), followed by P.vivax with 26 (16,25%). Although, in
1 cases (56,88%) was not possible to detect the plasmodium
pecies.
The malaria chemoprophylaxis was not made by 85
atients (53,12%). Those who did it, 38 (84,44%) took meﬂo-
uine.
The inpatient ratio was 43 (26,88%) of the 160, with a
atal case (0,63%).
Conclusion: The geographic areas of acquisition were
he former Portuguese Colonies in Africa, with 78,75% of
mported malaria.
The P. falciparum was the most frequent species.
Another problem was the diagnosis made by microscopy
ith lower parasitemia, that did not identify the plasmod-
um species. By this reason, more sensitive and accurate
ethods must be used.
To reduce risk of imported malaria, all travelers should
ave a pre-travel counselling, somajor investment is advised
o be made in this important emerging ﬁeld of Travel
edicine in Portugal.
oi:10.1016/j.ijid.2010.02.1800
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Background: Travelers to Central America (CAm), South
merica (SAm) and the Caribbean may face regional
ravel-related health risks. Our objective is to describe
emographics, trip characteristics and differences in pre-
ravel antimalarial prescriptions for travelers to CAm, SAm
nd the Caribbean.
Methods: Demographics, health, and trip information was
ollected for travelers seen in the 5 clinics of the Boston
rea Travel Medicine Network (BATMN) from March 1, 2008
o September 30, 2009. For analysis, Mexico was included in
he CAm category.
Results: Of 9203 travelers seen in participating clinics,
834 (30.8%) planned to visit CAm, SAm and the Caribbean
ncluding 1411 (49.8%) to SAm. Travelers to CAm and SAm
ere predominantly white (>80%) and less often black (2.6%)
ompared with 58.3% white and 20.8% black travelers to the
